- Home
- JSPR vs OSUR Comparison
JSPR vs OSUR Comparison
Compare JSPR & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JSPR
- OSUR
- Stock Information
- Founded
- JSPR 2018
- OSUR 2000
- Country
- JSPR United States
- OSUR United States
- Employees
- JSPR N/A
- OSUR N/A
- Industry
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- OSUR Medical/Dental Instruments
- Sector
- JSPR Health Care
- OSUR Health Care
- Exchange
- JSPR Nasdaq
- OSUR Nasdaq
- Market Cap
- JSPR 342.2M
- OSUR 289.4M
- IPO Year
- JSPR N/A
- OSUR 1986
- Fundamental
- Price
- JSPR $23.16
- OSUR $3.83
- Analyst Decision
- JSPR Strong Buy
- OSUR Buy
- Analyst Count
- JSPR 10
- OSUR 3
- Target Price
- JSPR $74.86
- OSUR $6.67
- AVG Volume (30 Days)
- JSPR 218.3K
- OSUR 754.9K
- Earning Date
- JSPR 11-07-2024
- OSUR 11-06-2024
- Dividend Yield
- JSPR N/A
- OSUR N/A
- EPS Growth
- JSPR N/A
- OSUR N/A
- EPS
- JSPR N/A
- OSUR 0.15
- Revenue
- JSPR N/A
- OSUR $224,263,000.00
- Revenue This Year
- JSPR N/A
- OSUR N/A
- Revenue Next Year
- JSPR N/A
- OSUR N/A
- P/E Ratio
- JSPR N/A
- OSUR $25.26
- Revenue Growth
- JSPR N/A
- OSUR N/A
- 52 Week Low
- JSPR $4.00
- OSUR $3.72
- 52 Week High
- JSPR $31.01
- OSUR $8.45
- Technical
- Relative Strength Index (RSI)
- JSPR 56.37
- OSUR 41.75
- Support Level
- JSPR $22.30
- OSUR $3.80
- Resistance Level
- JSPR $26.05
- OSUR $4.01
- Average True Range (ATR)
- JSPR 1.58
- OSUR 0.14
- MACD
- JSPR 0.05
- OSUR -0.00
- Stochastic Oscillator
- JSPR 58.02
- OSUR 30.56
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.